242 related articles for article (PubMed ID: 9863482)
1. Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rats.
Stadnicki A; Sartor RB; Janardham R; Stadnicka I; Adam AA; Blais C; Colman RW
Gut; 1998 Sep; 43(3):365-74. PubMed ID: 9863482
[TBL] [Abstract][Full Text] [Related]
2. Selective kallikrein-kinin system activation in inbred rats differentially susceptible to granulomatous enterocolitis.
Sartor RB; DeLa Cadena RA; Green KD; Stadnicki A; Davis SW; Schwab JH; Adam AA; Raymond P; Colman RW
Gastroenterology; 1996 May; 110(5):1467-81. PubMed ID: 8613052
[TBL] [Abstract][Full Text] [Related]
3. Kininogen deficiency modulates chronic intestinal inflammation in genetically susceptible rats.
Isordia-Salas I; Pixley RA; Li F; Sainz I; Sartor RB; Adam A; Colman RW
Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G180-6. PubMed ID: 12065305
[TBL] [Abstract][Full Text] [Related]
4. The Plasma Kallikrein-Kininogen Pathway Is Critical in the Pathogenesis of Colitis in Mice.
Wang B; Yang A; Zhao Z; He C; Liu Y; Colman RW; Dai J; Wu Y
Front Immunol; 2018; 9():21. PubMed ID: 29467753
[TBL] [Abstract][Full Text] [Related]
5. Activation of the kallikrein-kinin system in arthritis and enterocolitis in genetically susceptible rats: modulation by a selective plasma kallikrein inhibitor.
Colman RW; Stadnicki A; Kettner CA; Adam AA; DeLa Cadena RA; Sartor RB
Proc Assoc Am Physicians; 1997 Jan; 109(1):10-22. PubMed ID: 9010912
[TBL] [Abstract][Full Text] [Related]
6. Chronic intestinal inflammation and angiogenesis in genetically susceptible rats is modulated by kininogen deficiency.
Isordia-Salas I; Pixley RA; Li F; Sainz I; Balfour Sartor R; Adam A; Colman RW
Int Immunopharmacol; 2002 Dec; 2(13-14):1895-905. PubMed ID: 12489803
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of plasma kallikrein modulates chronic granulomatous intestinal and systemic inflammation in genetically susceptible rats.
Stadnicki A; Sartor RB; Janardham R; Majluf-Cruz A; Kettner CA; Adam AA; Colman RW
FASEB J; 1998 Mar; 12(3):325-33. PubMed ID: 9506476
[TBL] [Abstract][Full Text] [Related]
8. Factor XII-independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor.
Joseph K; Tholanikunnel BG; Kaplan AP
J Allergy Clin Immunol; 2009 Jul; 124(1):143-9. PubMed ID: 19342086
[TBL] [Abstract][Full Text] [Related]
9. [High molecular weight kininogen in inflammation and angiogenesis: a review of its properties and therapeutic applications].
Isordia-Salas I; Sainz IM; Pixley RA; Martínez-Murillo C; Colman RW
Rev Invest Clin; 2005; 57(6):802-13. PubMed ID: 16708906
[TBL] [Abstract][Full Text] [Related]
10. Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems.
Fang C; Schmaier AH
Pharmacol Res; 2020 Oct; 160():105096. PubMed ID: 32712319
[TBL] [Abstract][Full Text] [Related]
11. Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions.
Schmaier AH
Curr Opin Hematol; 2000 Sep; 7(5):261-5. PubMed ID: 10961574
[TBL] [Abstract][Full Text] [Related]
12. Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation.
DeLa Cadena RA; Laskin KJ; Pixley RA; Sartor RB; Schwab JH; Back N; Bedi GS; Fisher RS; Colman RW
Am J Physiol; 1991 Feb; 260(2 Pt 1):G213-9. PubMed ID: 1996642
[TBL] [Abstract][Full Text] [Related]
13. The role of plasma high molecular weight kininogen in experimental intestinal and systemic inflammation.
Isordia-Salas I; Pixley RA; Sáinz IM; Martínez-Murillo C; Colman RW
Arch Med Res; 2004; 35(5):369-77. PubMed ID: 15610905
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide injection into the cerebral ventricle evokes kininogen induction in the rat brain.
Takano M; Horie M; Yayama K; Okamoto H
Brain Res; 2003 Jul; 978(1-2):72-82. PubMed ID: 12834900
[TBL] [Abstract][Full Text] [Related]
15. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
[TBL] [Abstract][Full Text] [Related]
16. Physiologic activities of the contact activation system.
Schmaier AH
Thromb Res; 2014 May; 133 Suppl 1(0 1):S41-4. PubMed ID: 24759141
[TBL] [Abstract][Full Text] [Related]
17. A role for B1 and B2 kinin receptors in the modulation of T-kininogen during the acute phase response of inflammation.
Raymond P; Décarie A; Lantin F; Raut R; Morais R; Couture R; Adam A
Peptides; 1996; 17(7):1163-70. PubMed ID: 8959751
[TBL] [Abstract][Full Text] [Related]
18. Effect of Neurotropin on the activation of the plasma kallikrein-kinin system.
Nishikawa K; Reddigari SR; Silverberg M; Kuna PB; Yago H; Nagaki Y; Toyomaki Y; Suehiro S; Kaplan AP
Biochem Pharmacol; 1992 Mar; 43(6):1361-9. PubMed ID: 1562287
[TBL] [Abstract][Full Text] [Related]
19. Antisense inhibition of the brain kallikrein-kinin system.
Madeddu P; Parpaglia PP; Glorioso N; Chao L; Chao J
Hypertension; 1996 Dec; 28(6):980-7. PubMed ID: 8952586
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin B2 receptors mediate contraction in the normal and inflamed human gallbladder in vitro.
Trevisani M; Amadesi S; Schmidlin F; Poblete MT; Bardella E; Maggiore B; Harrison S; Figueroa CD; Tognetto M; Navarra G; Turini A; Bunnett NW; Geppetti P; De Giorgio R
Gastroenterology; 2003 Jul; 125(1):126-35. PubMed ID: 12851878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
